Cubist Systematic Strategies, LLC Supernus Pharmaceuticals, Inc. Transaction History
Cubist Systematic Strategies, LLC
- $15.1 Billion
- Q4 2024
A detailed history of Cubist Systematic Strategies, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 139,522 shares of SUPN stock, worth $4.43 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
139,522
Previous 13,361
944.25%
Holding current value
$4.43 Million
Previous $416,000
1112.74%
% of portfolio
0.03%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding SUPN
# of Institutions
303Shares Held
60.6MCall Options Held
22.3KPut Options Held
6K-
Black Rock Inc. New York, NY10.4MShares$330 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.15MShares$195 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.84MShares$154 Million2.47% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$91.4 Million0.03% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$83.5 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.7B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...